Rocket Corp (RCKT) - Cash per Single Share

Symbol and logo of brand Rocket Corp (RCKT)

Rocket Pharmaceuticals (RCKT) funding relies on reimbursements from insurers and government agencies for the high-cost treatment of rare pathologies. The cash-per-share trend confirms investor confidence, with 2.40 shaping the current metric. The development of lifelong gene therapies creates a long-term monopoly through patents, while the sector's independence from macroeconomic fluctuations transforms the asset into a reliable defensive tool.

RCKT Rocket Pharmaceuticals, Inc.: Cash per Single Share in the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Rocket Pharma (RCKT)

- market capitalization indicators:
- cash and cash flow data:
Summary company analysis:RCKT Rocket Pharmaceuticals Inc
Finished products of Rocket Pharmaceuticals, Inc.

The monopoly potential of Rocket Pharmaceuticals (RCKT) gene therapy requires significant expenditures to maintain a long-term patent cycle. The current cash per share of 2.40 reflects the portion of liquid capital in each share, excluding speculative market revaluation. Analyzing this trend allows for an assessment of the issuer's financial stability and its ability to fund development without the risk of bankruptcy.

Key competitors

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|FDMT (4D Molecular Therapeutics Inc) - Cash Funds per Share|Cash per Single Share LXEO|Cash Funds per Share KRRO|Cash per Share EDIT|SLN - Cash on Hand per Share|Cash per Share PRQR (ProQR)|CDXS - Cash per Single Share|Sangamo Therapeutics Inc. - Cash per Share|NAUT - Cash per Share|MGX: Cash per Share|Cash per Single Share Precision BioSciences, Inc.|GBIO (Generation Bio) - Cash per Share|Boundless Bio Inc. (BOLD) - Cash Funds Calculated per Share|Cash per Single Share XCUR (exicuretx.com)|Imunon Inc - Cash Funds per Single Share|Cash per Share PHIO (Phio Pharmaceuticals Corp)|Amount of Cash per Share MBIO|RNAZ - Cash Funds per Share|Amount of Cash per Share BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Cash Funds per Share|Bluebird Bio - Amount of Cash per Share|IPA (ImmunoPrecise Antibodies Ltd) - Cash per Share|Cash on Hand per Share Omega Therapeutics, Inc. OMGA|Cash per Share OMIC|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology